name
|
formula
|
system
|
space group
|
unit cell Å
|
volume
|
density
|
comment
|
ref
|
lithium sulfate monohydrate oxalate
|
?
|
triclinic
|
P1
|
a = 3.4014 b = 5.0397 c = 6.120 α = 78.62° β= 84.95°
γ = 81.14°
|
101.45
|
|
band gap 4.57 eV
dielectric constant 29.7
stable below 83°C
piezoelectric coefficient 6pC/N
|
[3]
|
homopiperazinium dimagnesium dioxalate sulfate dihydrate
|
C5H14N2•Mg2•[C2O4]2•SO4•2H2O
|
monoclinic
|
Ia
|
a=11.5673 b=27.3352 c=16.6097 β=95.255° Z=12
|
5229.8
|
1.749
|
colourless
|
[4]
|
piperazinium magnesium oxalate sulfate hydrate
|
C4H12N2•Mg•[C2O4]•SO4•H2O
|
monoclinic
|
P21/c
|
a=12.7330 b=8.9240 c=11.8172 β=115.502° Z=4
|
1211.95
|
1.724
|
colourless
|
[4]
|
potassium sulphato oxalate
|
?
|
triclinic
|
|
a = 6.37 b = 7.03 c = 10.61 α = 93.96 ̊ β = 101.37 ̊ γ = 100.1 ̊
|
|
|
colourless > 300nm; SHG 1.6×KDP
|
[5]
|
bapp = 1,4-bis(3-aminopropyl)piperazine
|
(H4bapp)0.5·VO(SO4)(C2O4)
|
triclinic
|
P1
|
a=6.2031 b=8.6599 c=12.1853 α=77.130° β=76.207° γ=82.987°
|
|
|
|
[6]
|
bipy=4,4′-bipyridine; (μ2-Oxalato-O,O',O'',O''')-tetrakis(2,2'-bipyridine)-di-chromium(iii) disulfate 2,2'-bipyridine solvate monohydrate
|
[Cr2(bipy)4(C2O4)](SO4)·(bipy)0.5·H2O
|
triclinic
|
P1
|
a=11.610 b=12.668 c=17.155 α=77.297° β=83.957° γ=85.458°
|
|
|
|
[7]
|
depa = 3-(diethylamino)propylamine
|
H2depa⋅Mn2(SO4)(C2O4)2(H2O)⋅H2O
|
orthorhombic
|
Pbca
|
a=14.6293 b=15.6671 c=17.3579
|
|
|
|
[6]
|
hpip = homopiperazine
|
H2hpip·Mn2(SO4)(C2O4)2(H2O)
|
orthorhombic
|
P212121
|
a=9.9066 b=12.4496 c=13.6640
|
|
|
|
[8]
|
pip = piperazine; piperazinediium (μ-oxalato)-bis(μ-sulfato)-diaqua-di-manganese(ii) dihydrate
|
H2pip·Mn2(SO4)2(C2O4)(H2O)4
|
triclinic
|
P1
|
a 6.6501(4)Å b 7.7034(4)Å c 9.6810(5)Å, α 69.850(4)° β 70.553(5)° γ 83.921(4)°
|
|
|
|
[9]
|
ipa = 3,3′-iminobis(N,N-dimethylpropylamine) bis(3-dimethylammoniopropyl)ammonium pentakis(μ-oxalato)-bis(μ-sulfato)-tetra-manganese(ii) dihydrate
|
H3ipa⋅Mn2(SO4)(C2O4)2.5·H2O
|
triclinic
|
P1
|
a 9.9379(6)Å b 11.2423(6)Å c 11.6390(7)Å, α 86.793(5)° β 81.644(5)° γ 74.481(5)°
|
|
|
|
[9]
|
dpta = dipropylenetriamine; bis(3-ammoniopropyl)ammonium tris(μ-oxalato)-bis(μ-sulfato)-bis(sulfato)-hexa-aqua-tetra-manganese(ii)
|
H3dpta⋅Mn2(SO4)2(C2O4)1.5(H2O)3
|
triclinic
|
P1
|
a 8.6819(3)Å b 10.1689(3)Å c 13.7456(5)Å, α 70.197(3)° β 73.406(3)° γ 87.636(3)°
|
|
|
|
[9]
|
dmen = N,N-dimethylethylenediamine
|
H2dmen·Mn(SO4)(C2O4)
|
monoclinic
|
P21/n
|
a=9.8603 b=12.6525 c=10.0837 β=113.002°
|
|
|
|
[10]
|
bis(N,N-dimethylpropane-1,3-diaminium) bis(μ-oxalato)-bis(μ-sulfato)-di-manganese
|
|
triclinic
|
P1
|
a=8.5307 b=9.0432 c=9.6913 α=69.632° β=64.639° γ=88.148°
|
|
|
|
[11]
|
butane-1,4-diaminium bis(μ-oxalato)-(μ-sulfato)-aqua-di-manganese
|
|
triclinic
|
P1
|
a=8.5468 b=10.0050 c=10.6532 α=75.445° β=79.787° γ=71.848°
|
|
|
|
[11]
|
|
Na2Fe(C2O4)SO4⋅H2O
|
|
|
|
|
|
orange; most air sensitive
|
[12]
|
(μ-oxalato)-(μ-sulfato)-iron-di-potassium
|
K2[Fe(C2O4)(SO4)]
|
monoclinic
|
P21/c
|
a=5.8735 b=10.2169 c=13.1491 β=91.226°
|
|
|
|
[13]
|
tris(μ-oxalato)-bis(μ-sulfato)-tri-iron-tetra-potassium
|
K4[Fe3(C2O4)3(SO4)2]
|
monoclinic
|
P21/c
|
a 13.739 b 5.496 c 12.774 β 97.677°
|
|
|
|
[13]
|
acid oxalo-bisulfate of roseocobalt ??
|
Co2(HN3)10(C2O4)(SO4)2 ·H2O·H2C2O4
|
|
|
|
|
|
speculative
|
[14]
|
|
[Co(NH3)4(C2O4)]2SO4·2H2O
|
|
|
|
|
|
|
[15]
|
|
[Co(NH3)4(C2O4)]2S2O6
|
|
|
|
|
|
|
[15]
|
tris(μ-aqua)-tris(μ-oxalato)-tris(μ-sulfato)-tri-cobalt-hexa-sodium
|
Na2[Co(C2O4)(SO4)]·H2O
|
hexagonal
|
P62m
|
a=10.2322 c=6.4774
|
|
|
|
[13]
|
tris(μ-oxalato)-bis(μ-sulfato)-bis(2-((2-aminoethyl)amino)ethanaminium)-tetraaqua-tetra-cobalt
|
|
triclinic
|
P1
|
a=8.6065 b=9.5595 c=9.5987 α=77.884° β=82.744° γ=87.356°
|
|
|
|
[16]
|
bis(μ-oxalato)-bis(μ-sulfato)-bis(4-(2-aminoethyl)piperazin-1-ium)-tri-cobalt
|
|
triclinic
|
P1
|
a=8.4331 b=9.4691 c=9.5144 α=71.522° β=64.356° γ=89.622°
|
|
|
|
[16]
|
1,4-dimethylpiperazinedi-ium bis(μ-oxalato)-hepta-aqua-tri-cobalt bis(sulfate)
|
(H2dmp)(SO4)3Co3(C2O4)2(H2O)7
|
orthorhombic
|
Pnma
|
a=11.1050 b=16.4221 c=13.9815
|
|
|
violet
|
[17]
|
Bis[tris(oxamide dioxime-2N,N')cobalt(III)] oxalate bis(sulfate) dodecahydrate
|
[Co(C2H6N4O2)3]2(C2O4)(SO4)212H2O
|
triclinic
|
P1
|
a = 9.430 b = 11.782 c = 12.812 α = 65.494° β = 83.088° γ = 86.735° Z=1
|
1285.7
|
1.698
|
at 193K; red
|
[18]
|
homopiperazinium dizinc dioxalate sulfate hydrate
|
C5H14N2•Zn2•[C2O4]2•SO4•H2O
|
monoclinic
|
P21
|
a=15.8356 b=13.5022 c=15.9578 β=109.075° Z=8
|
3224.7
|
2.154
|
colourless
|
[4]
|
homopiperazinium dizinc dioxalate sulfate dihydrate
|
C5H14N2•Zn2•[C2O4]2•SO4•2H2O
|
monoclinic
|
Ia
|
a=11.5681 b=27.1755 c=16.5979 β=94.946° Z=12
|
5198.4
|
2.074
|
colourless
|
[4]
|
bis(4-(2-aminoethyl)piperazin-1-ium)-bis(μ-oxalato)-bis(μ-sulfato)-tri-zinc
|
|
triclinic
|
P1
|
a=8.407 b=9.523 c=9.543 α=108.39° β=115.52° γ=90.17°
|
|
|
|
[11]
|
1,4-dimethylpiperazinedi-ium bis(sulfate) bis(μ-oxalato)-hepta-aqua-tri-zinc
|
(H2dmp)(SO4)3Zn3(C2O4)2(H2O)7
|
orthorhombic
|
Pnma
|
a 11.1058 b 16.3449 c 14.0064
|
|
|
colourless
|
[17]
|
|
(Hgly)2·Zn(SO4)(C2O4)
|
monoclinic
|
C2
|
a 19.1509 b 5.4000 c 12.8206 β 102.878°
|
|
|
|
[19]
|
|
RbFe(SO4)(C2O4)0.5·H2O
|
monoclinic
|
P21/c
|
a = 7.9193, b = 9.4907, c = 8.8090, β = 95.180°, Z = 4
|
|
|
|
[20]
|
bis(μ3-sulfato)-bis(μ2-oxalato)-diaqua-di-yttrium diammonium
|
[NH4][Y(H2O)(SO4)(C2O4)]
|
monoclinic
|
P21/n
|
a=6.534 b=8.527 c=13.745 β=92.87°
|
|
|
|
[21]
|
bis(μ3-Sulfato-O,O,O',O'',O''')-(μ2-oxalato-O,O',O'',O''')-(μ2-piperazine-diium-1,4-diacetato-O,O')-diaqua-di-yttrium(iii)
|
Y2(H2pda)(C2O4)(SO4)2(H2O)2]
|
monoclinic
|
C2/c
|
a 19.392 b 6.2757 c 16.999 β 108.279°
|
|
|
|
[22]
|
levinsonite-(Y)
|
(Y,Nd,Ce)Al(SO4)2(C2O4) · 12H2O
|
monoclinic
|
P2/n
|
a = 10.289 Å, b = 9.234, c = 11.015
β = 108.50°
|
992.4
|
2.181
|
Biaxial (+) Refractive index:
nα = 1.480 nβ = 1.490 nγ = 1.550
|
[23][24]
|
thfa = tetrahydrofurfurylamine; bis(tetrahydrofurfurylammonium) tris(μ-oxalato)-(μ-sulfato)-di-indium(iii) dihydrate
|
(Hthfa)2·In2(SO4)(C2O4)3·2H2O
|
monoclinic
|
P21/c
|
a=10.7581 b=12.9985 c=19.9093 β=92.876°
|
|
|
|
[8]
|
bapp = N,N′-bis(3-aminopropyl)piperazine
|
H4bapp·[In2(SO4)3(C2O4)2(H2O)2]·H2O
|
monoclinic
|
I2/a
|
a=13.8931 b=14.6792 c=15.2418 β=111.153°
|
|
|
|
[10]
|
bis(1-ethylpiperazinedi-ium) tris(μ-oxalato)-bis(sulfato)-di-indium
|
H2epip·[In2(SO4)2(C2O4)3]
|
tetragonal
|
I41/a
|
a=26.0767 c=8.9467
|
|
|
colourless
|
[17]
|
Piperazinediium bis(μ2-oxalato-O,O',O'',O''')-bis(μ2-sulfato-O,O')-diaqua-di-indium dihydrate
|
[C4N2H12]0.5InSO4C2O4·2H2O
|
monoclinic
|
P21/c
|
a=6.478 b=11.067 c=14.317 β=100.302°
|
|
|
|
[25]
|
|
Hgly·In(SO4)(C2O4)(gly)
|
monoclinic
|
P21
|
a 6.5179(2)Å b 10.9928(3)Å c 18.0301(6)Å, α 90° β 93.9700(10)°
|
|
|
|
[19]
|
|
CsMn(SO4)(C2O4)0.5·H2O
|
monoclinic
|
P21/c
|
a = 8.065, b = 9.610, c = 9.219, β = 94.564°, Z = 4
|
|
|
|
[20]
|
|
CsFe(SO4)(C2O4)0.5·H2O
|
monoclinic
|
P21/c
|
a = 7.9377, b = 9.5757, c = 9.1474, β = 96.104°, Z = 4
|
|
|
|
[20]
|
|
La2(C2O4)(SO4)2(H2O)3
|
monoclinic
|
P21/n
|
a=9.838 b=9.817 c=13.111 β=104.258°
|
|
|
|
[26]
|
bis(μ3-sulfato)-bis(μ2-oxalato)-diaqua-di-lanthanum diammonium
|
[NH4][La(H2O)(SO4)(C2O4)]
|
monoclinic
|
P21/n
|
a=6.629 b=8.673 c=13.867 β=93.35°
|
|
|
|
[21]
|
(μ4-Piperazine-diium-1,4-diacetato-O,O',O'',O''')-bis(μ3-sulfato-O,O',O'')-(μ2-oxalato-O,O',O'',O''')-diaqua-di-cerium(iii) dihydrate
|
Ce2(H2pda)(C2O4)(SO4)2(H2O)2 · 2H2O
|
monoclinic
|
C2/c
|
a 19.353 b 6.836 c 16.400 β 94.312°
|
|
|
|
[22]
|
coskrenite-(Ce)
|
(Ce,Nd,La)2(C2O4)(SO4)2 · 12H2O
|
triclinic
|
|
a = 6.007(1) Å, b = 8.368(2) Å, c = 9.189(2) Å
α = 99.90(2)°, β = 105.55(2)°, γ = 107.71(2)°
|
|
2.881
|
Biaxial (-) refractive indices: nα = 1.544 nβ = 1.578 nγ = 1.602; Birefringence: δ = 0.058
|
[27][28]
|
zugshunstite-(Ce)
|
(Ce,Nd,La)Al(SO4)2(C2O4) · 12H2O
|
Monoclinic
|
C2/c
|
a = 8.718 b = 18.313 c = 13.128
β = 93.90°
|
2091
|
2.121
|
Large REE; pink in incandescent light; blue in fluorescent light; Biaxial (+) refractive index: nα = 1.455 nβ = 1.485 nγ = 1.528;
|
[29][24]
|
(μ4-Piperazine-diium-1,4-diacetato-O,O',O'',O''')-bis(μ3-sulfato-O,O',O'')-(μ2-oxalato-O,O',O'',O''')-diaqua-di-praseodymium(iii) dihydrate
|
Pr2(H2pda)(C2O4)(SO4)2(H2O)2 · 2H2O
|
monoclinic
|
C2/c
|
a 19.295 b 6.8100 c 16.377 β 94.369°
|
|
|
|
[22]
|
heptakis(μ-oxalato)-bis(μ-sulfato)-tetradecaaqua-hexa-neodymium dihydrate
|
Nd6(SO4)2(C2O4)7(H2O)14·H2O
|
triclinic
|
P1
|
a=6.0817 b=11.8807 c=16.0749 α=73.230° β=80.873° γ=88.976°
|
|
|
|
[30]
|
N,N'-dimethylethane-1,2-diaminium tetrakis(μ-sulfato)-tris(μ-oxalato)-octaaqua-tetra-neodymium
|
[C4H14N2]·Nd4(SO4)4(C2O4)3(H2O)8
|
triclinic
|
P1
|
a=7.0649 b=11.2771 c=11.8318 α=67.370° β=80.035° γ=82.821°
|
|
|
|
[30]
|
bis(μ3-Sulfato-O,O,O',O'',O''')-(μ2-oxalato-O,O',O'',O''')-(μ2-piperazine-diium-1,4-diacetato-O,O')-diaqua-di-neodymium(iii)
|
Nd2(H2pda)(C2O4)(SO4)2(H2O)2]
|
monoclinic
|
C2/c
|
a=19.702 b=6.348 c=17.352 β=109.973°
|
|
|
|
[22]
|
bis(1,4-Diazoniabicyclo[2.2.2]octane) tetrakis(μ2-oxalato-O,O',O'',O''')-tetrakis(μ2-sulfato-O,O',O'')-octa-aqua-tetra-neodymium(iii) dihydrate
|
[C6N2H14][Nd2(C2O4)2(SO4)2(H2O)4]·H2O
|
monoclinic
|
P21/c
|
a=8.523 b=28.628 c=9.306 β=96.497°
|
|
|
|
[31]
|
(μ4-Piperazine-diium-1,4-diacetato-O,O',O'',O''')-bis(μ3-sulfato-O,O',O'')-(μ2-oxalato-O,O',O'',O''')-diaqua-di-europium(iii) dihydrate
|
Eu2(H2pda)(C2O4)(SO4)2(H2O)2 · 2H2O
|
monoclinic
|
C2/c
|
a=19.143 b=6.722 c=16.323 β=94.58°
|
|
|
|
[22]
|
(μ5-Oxalato)-(μ3-sulfato)-(μ2-aqua)-aqua-europium-silver
|
AgEu(μ5-C2O4)(SO4)(H2O)2
|
monoclinic
|
P21/c
|
a=6.627 b=13.848 c=8.983 β=96.985°
|
|
|
|
[32]
|
tetrakis(μ2-oxalato)-bis(μ2-sulfato)-dodeca-aqua-tetra-erbium monohydrate
|
Er4(SO4)2(C2O4)4(H2O)12·H2O
|
monoclinic
|
P21/c
|
a=10.5598 b=12.8404 c=12.0835 β=93.327°
|
|
|
|
[30]
|
bis(μ3-sulfato)-bis(μ2-oxalato)-diaqua-di-samarium diammonium
|
[NH4][Sm(H2O)(SO4)(C2O4)]
|
monoclinic
|
P21/n
|
a=6.619 b=8.660 c=13.853 β=93.30°
|
|
|
|
[21]
|
(μ5-Oxalato)-(μ3-sulfato)-(μ2-aqua)-aqua-samarium-silver
|
AgSm(μ5-C2O4)(SO4)(H2O)2
|
monoclinic
|
P21/c
|
a=6.630 b=13.829 c=9.001 β=97.128°
|
|
|
|
[32]
|
|
(NH4)[Gd(C2O4)(SO4)(H2O)]
|
|
|
|
|
|
large magnetocaloric effect
|
[33]
|
|
K[Gd(C2O4)(SO4)(H2O)]
|
monoclinic
|
P21/c
|
a = 6.5849 b = 8.5660 c = 14.7660(2) Å, β = 112.470° Z=4
|
769.66
|
3.439
|
colourless
|
[34]
|
potassium aquaterbium(III) oxalate sulfate
|
KTb(C2O4)(SO4)(H2O)
|
monoclinic
|
|
a = 6.527 b = 8.507 c = 14.591 β = 112.65° Z=4
|
747.7
|
|
at 113K; colourless
|
[35]
|
(μ6-Oxalato)-(μ4-oxalato)-bis(μ3-sulfato)-diaqua-di-silver-di-terbium
|
AgTb(μ4-C2O4)0.5(μ6-C2O4)0.5(SO4)(H2O)
|
monoclinic
|
C2/m
|
a=13.693 b=6.889 c=9.0885 β=116.73°
|
|
|
|
[32]
|
(μ6-Oxalato)-(μ4-oxalato)-bis(μ3-sulfato)-diaqua-di-dysprosium-di-silver
|
AgDy(μ4-C2O4)0.5(μ6-C2O4)0.5(SO4)(H2O)
|
monoclinic
|
C2/m
|
a=13.683 b=6.881 c=9.080 β=116.731°
|
|
|
|
[32]
|
bis(1-ethyl-3-methyl-1H-imidazol-3-ium) (μ-oxalato)-bis(μ-sulfato)-tetraoxo-di-uranium monohydrate
|
|
monoclinic
|
P21/c
|
a=11.579 b=17.312 c=13.694 β=108.178°
|
|
|
yellow
|
[36]
|
|
(NH4)4[(UO2)2(C2O4)(SO4)2(NCS)2]⋅6H2O
|
orthorhombic
|
Pbam
|
a = 12.0177 b = 18.6182 c = 6.757 Z=2
|
|
|
|
[37]
|
Tetrapotassium bis(μ2-oxalato)-tetraoxo-bis(sulfato)-di-uranium(vi) hexahydrate
|
K2[UO2(C2O4)SO4] · 3H2O
|
triclinic
|
P1
|
a=5.743 b=9.544 c=11.845 α=89.49° β=84.95° γ=83.01°
|
|
|
|
[38]
|
|
K4[(UO2)2C2O4(SO4)2(NCS)2]
|
orthorhombic
|
Pbam
|
a = 11.5548 b = 7.0847 c = 13.5172 β = 93.130° Z=2
|
1104.90
|
|
|
[39]
|
Di-rubidium dioxo-(oxalato-O,O')-(μ3-sulfato)-uranium monohydrate
|
Rb2[UO2SO4(C2O4)] · H2O
|
orthorhombic
|
Pna21
|
a=9.720 b=17.037 c=6.852
|
|
|
|
[38][40]
|
|
Rb4[(UO2)2C2O4(SO4)2(NCS)2]
|
orthorhombic
|
Pbam
|
a = 11.5854 b = 7.3841 c = 13.9072 β = 95.754 V = Z=2
|
1183.7
|
|
|
[39]
|
|
Cs4[(UO2)2(C2O4)(SO4)2(NCS)2] · 4H2O
|
orthorhombic
|
Pbam
|
a = 11.6539 b = 18.379 c = 6.7216 Z=2
|
|
|
|
[37]
|
Tetracesium dioxo-bis(oxalato-O,O')-(sulfato-O)-uranium(vi) hydrate
|
Cs4[UO2(C2O4)2SO4] · 2.7H2O
|
orthorhombic
|
Pbca
|
a=9.546 b=21.119 c=21.499
|
|
|
|
[38]
|